SLDB
SLDB
NASDAQ · Biotechnology

Solid Biosciences Inc

$7.26
+0.58 (+8.68%)
As of Mar 25, 2:50 PM ET ·
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 18 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target +50.1% upside
Low Target $9.47
Average Target $10.90
High Target $14.24
Current Price $7.26
Current
$7.26
Target
$10.90
$9.47 $10.90 avg $14.24
Scenario Analysis
Bear Case
$9.47
30.4%
Low target
Base Case
$10.90
+50.1%
Avg target
Bull Case
$14.24
+96.1%
High target
Risk/Reward
3.2x
Highly favorable
Price in Context
52-Week High
$7.37
-1.5% from high
52-Week Low
$2.41
+201.2% from low
Target vs 52W High
$10.90
+47.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%